Makes you wonder why the FDA is more tolerant with some toxic chemo drugs. Could it be that Big Pharma rules? With all the potential Kevetrin has, it will be interesting. Big Pharma will make it easier for Kevetrin to successfully make it to market. Makes sense to me.
Market Data 
Markets 
AI
